Medistim ASA (STO:MEDIO)

Market Cap	3.82B +45.2%
Revenue (ttm)	624.70M +22.2%
Net Income	134.36M +40.1%
EPS	7.35 +40.3%
Shares Out	n/a
PE Ratio	28.40
Forward PE	25.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25
Average Volume	170
Open	220.00
Previous Close	n/a
Day's Range	220.00 - 220.00
52-Week Range	154.00 - 284.00
Beta	n/a
RSI	40.56
Earnings Date	Feb 27, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 154
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MEDIO

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.

Financial numbers in NOK